GR861837B - Novel polypeptide of an anticoagulant activity method for preparing them their usage and means containing them - Google Patents

Novel polypeptide of an anticoagulant activity method for preparing them their usage and means containing them

Info

Publication number
GR861837B
GR861837B GR861837A GR860101837A GR861837B GR 861837 B GR861837 B GR 861837B GR 861837 A GR861837 A GR 861837A GR 860101837 A GR860101837 A GR 860101837A GR 861837 B GR861837 B GR 861837B
Authority
GR
Greece
Prior art keywords
usage
preparing
novel polypeptide
anticoagulant activity
means containing
Prior art date
Application number
GR861837A
Other languages
English (en)
Inventor
Kramer Prof Dr Martin
Tripier Dr Dominique
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853525428 external-priority patent/DE3525428A1/de
Priority claimed from DE19863601032 external-priority patent/DE3601032A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of GR861837B publication Critical patent/GR861837B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/141—Feedstock
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR861837A 1985-07-17 1986-07-15 Novel polypeptide of an anticoagulant activity method for preparing them their usage and means containing them GR861837B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853525428 DE3525428A1 (de) 1985-07-17 1985-07-17 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE19863601032 DE3601032A1 (de) 1986-01-16 1986-01-16 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (1)

Publication Number Publication Date
GR861837B true GR861837B (en) 1986-11-11

Family

ID=25834067

Family Applications (1)

Application Number Title Priority Date Filing Date
GR861837A GR861837B (en) 1985-07-17 1986-07-15 Novel polypeptide of an anticoagulant activity method for preparing them their usage and means containing them

Country Status (16)

Country Link
US (1) US4791100A (el)
EP (1) EP0209061B1 (el)
JP (1) JPH0764875B2 (el)
KR (1) KR940000758B1 (el)
AU (1) AU593820B2 (el)
CA (1) CA1340102C (el)
DE (1) DE3689525D1 (el)
DK (1) DK173509B1 (el)
ES (1) ES2000216A6 (el)
FI (1) FI862950A (el)
GR (1) GR861837B (el)
HU (1) HUT41418A (el)
IE (1) IE61569B1 (el)
IL (1) IL79424A (el)
NO (1) NO862876L (el)
PT (1) PT82993B (el)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE64956T1 (de) * 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
ES2055149T3 (es) * 1985-04-11 1994-08-16 Hoechst Ag Derivado de hirudina.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
JPH03504501A (ja) * 1988-05-27 1991-10-03 マゲイニン　サイエンセス　インコーポレーテッド 両親媒性ペプチドとその用途
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
IL86856A0 (en) * 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same
IL87004A (en) * 1988-07-06 1992-08-18 Technion Res & Dev Foundation Method and apparatus for bioaffinity separation
GB8817160D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Novel proteins
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
GB8826428D0 (en) * 1988-11-11 1988-12-14 Biopharm Ltd Antithrombin
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5187155A (en) * 1989-06-23 1993-02-16 Board Of Regents, The University Of Texas System Anticoagulant peptides
CA2026377A1 (en) * 1989-10-03 1991-04-04 John L. Krstenansky Radiolabeled anticoagulant peptides
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5190919A (en) * 1989-11-13 1993-03-02 Board Of Regents, The University Of Texas System Antihemostatic factor vii peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
EP0514464A4 (en) * 1990-02-08 1993-04-28 Magainin Sciences, Inc. Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
CA2035917C (en) * 1990-02-13 2001-10-02 John L. Krstenansky Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
WO1991017760A1 (en) * 1990-05-14 1991-11-28 Magainin Sciences Inc. Composition of and treatment with biologically active peptides having d-amino acid residues
IE990233A1 (en) * 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
EP0559647A1 (en) * 1990-06-27 1993-09-15 Magainin Pharmaceuticals Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
US5428009A (en) * 1990-07-16 1995-06-27 Merck & Co., Inc. Lipopeptide derivatives
CA2047527A1 (en) * 1990-07-24 1992-01-25 Christopher Dunwiddie Method for administering a therapeutic anticoagulant
DE4031731A1 (de) * 1990-10-06 1992-04-09 Basf Ag Protein aus hirudo medicinalis
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
US5385884A (en) * 1991-08-27 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
JPH07500342A (ja) * 1991-10-16 1995-01-12 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア 生物学的活性ペプチドおよび抗生物質を有する組成物およびこれを用いた治療
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
US5824641A (en) * 1993-04-09 1998-10-20 Bio-Technology General Corp Method of treating of preventing influenza
DE69429858D1 (de) * 1993-04-09 2002-03-21 Bio Technology General Corp Herstellung eines rekombinanten inhibitors des faktors xa des blutegels hirudo medicinalis
GB9309509D0 (en) * 1993-05-07 1993-06-23 Merck Patent Gmbh Thrombin inhibitors
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69624087T2 (de) 1996-01-31 2003-06-05 Sumitomo Bakelite Co Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
US6699836B2 (en) 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
US6518243B1 (en) 1999-04-02 2003-02-11 Trustees Of Princeton University Desleucyl glycopeptide antibiotics and methods of making same
SG171340A1 (en) * 2008-11-19 2011-07-28 Avantor Performance Mat Inc New chromatographic media based on phenoxy alkyl and alkoxy-or phenoxy-phenyl alkyl ligands
CN102373216B (zh) * 2011-10-28 2013-06-05 元昊 一种含有医用水蛭素基因的重组真核汉逊酵母工程菌株的构建及重组水蛭素的生产工艺
CN113956339B (zh) * 2021-10-28 2023-02-24 中国药科大学 宽体金线蛭抗凝血因子XIa多肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
CA1341414C (fr) * 1984-03-27 2002-12-31 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3438296A1 (de) * 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten

Also Published As

Publication number Publication date
NO862876L (no) 1987-01-19
IE61569B1 (en) 1994-11-16
EP0209061A2 (de) 1987-01-21
DK338486D0 (da) 1986-07-16
IL79424A0 (en) 1986-10-31
AU6023386A (en) 1987-01-22
NO862876D0 (no) 1986-07-16
DK173509B1 (da) 2001-01-15
JPH0764875B2 (ja) 1995-07-12
ES2000216A6 (es) 1988-01-16
IL79424A (en) 1992-02-16
PT82993B (pt) 1989-01-30
AU593820B2 (en) 1990-02-22
IE861902L (en) 1987-01-17
KR870001237A (ko) 1987-03-12
FI862950A (fi) 1987-01-18
FI862950A0 (fi) 1986-07-15
CA1340102C (en) 1998-10-27
HUT41418A (en) 1987-04-28
US4791100A (en) 1988-12-13
PT82993A (de) 1986-08-01
DK338486A (da) 1987-01-18
DE3689525D1 (de) 1994-02-24
EP0209061B1 (de) 1994-01-12
KR940000758B1 (ko) 1994-01-29
JPS6222799A (ja) 1987-01-30
EP0209061A3 (en) 1989-03-15

Similar Documents

Publication Publication Date Title
GR861837B (en) Novel polypeptide of an anticoagulant activity method for preparing them their usage and means containing them
ZA875841B (en) Method of culturing leukocytes
GB2197219B (en) Method of filtering
CH0225254H1 (en) Specific antibody-containing substance from eggs and method of production and use thereof
EP0193356A3 (en) Method for analysis of subpopulations of blood cells
PL261052A1 (en) Method of obtaining stable variety of thorasemide
PL263078A1 (en) Method of obtaining novel benzamides
PL268313A1 (en) Method of obtaining novel ocylopeptides
BG40573A1 (en) Method for simultaneous preparing of acetoxymethyllongipholene and isolongipholene
RO92738B1 (ro) Metoda de analgezie rapida
PL254237A1 (en) Method of obtaining stable proteinous fraction of human serum
PL252903A1 (en) Method of obtaining novel polypeptides
PL253417A1 (en) Method of obtaining n-2-aminoethyl-3-aminopropylotrimetoxysilane
PL257233A1 (en) Method of obtaining perfluoroacylobenzenosulfonates
GB8517627D0 (en) Method of testing
PL256772A1 (en) Method of preparing an ensilage
PL256954A2 (en) Method of obtaining nitropigment preparations
PL141572B2 (en) Method of obtaining nitropigment preparations
BG40067A1 (en) Method for preparing of n- benzyloxycarbonyl- l- triptophyl- l- serine- hydrazide
BG46958A1 (en) Method for preparing of dinitronaphthalene
BG40410A1 (en) Method for preparing of amicazine
CS622986A2 (en) Method of diamino-platinous complex preparation
CS823685A1 (en) Method of cis-diaminodichloroplatinum complex preparation
IE852430L (en) Method of measuring enzymic activity of chymopapains
IL77162A0 (en) Compositions and method for the modification of insulin activity